The aB-crystallin/small heat shock protein gene is expressed very highly in the mouse eye lens and to a lesser extent in many other nonocular tissues, including the heart, skeletal muscle and brain. Previously we showed in transgenic mice that lens-speci®c aB-crystallin promoter activity is directed by a proximal promoter fragment (2164/144) and that non-lens promoter activity depends on an upstream enhancer (2427/2259) composed of at least 5 cis-control elements. Here we have used truncated aB-crystallin promoter-CAT transgenes to test by biphasic CAT assays and/or histochemistry for speci®c expression in the cornea and lens. Deletion either of 87 bp (2427/2340) from the 5 H end of the aB-crystallin enhancer or of the whole enhancer (2427/2258) abolished aB-crystallin promoter activity in all tissues except the lens and corneal epithelium when examined by the biphasic CAT assay in 4±5-week-old transgenic mice. These truncations also lowered promoter strength in the lens. The 2426/144-CAT, 2339/144-CAT and 2164/144-CAT (previously thought to be lens-speci®c in transgenic mice) transgenes were all expressed in the 4±6-week-old corneal epithelium when examined histochemically. Immunohistochemical staining con®rmed the presence of endogenous aB-crystallin in the mature corneal epithelial cells. CAT gene expression driven by the aB-crystallin promoter with or without the enhancer was evident in the embryonic and 4±6-week-old lens. By contrast, activity of the aB-crystallin promoter/enhancer-CAT transgene was not detectable in the corneal epithelium before birth. Taken together, these results indicate that the intact enhancer of the aB-crystallin/small heat shock protein gene is required for promoter activity in all tissues tested except the lens and cornea. q
Introduction
In the vertebrate eye an image is cast onto the retinal photoreceptor cells by the combined refractive power of the transparent cornea and lens (Land, 1988) . Except for a surrounding capsule, the lens is composed entirely of anterior, cuboidal epithelial cells and terminally differentiated, elongated, posterior ®ber cells that lose their nuclei and other organelles in the central region of the lens (Piatigorsky, 1981) . A diverse group of proteins called crystallins accumulate in the lens and are responsible for transparency (Wistow and Piatigorsky, 1988; de Jong et al., 1989; Piatigorsky and Wistow, 1989; Bloemendal and de Jong, 1991) .
Although often active at low levels in numerous tissues, crystallin promoters/enhancers have been studied intensively with respect to their high activity in the lens (Li et al., 1994; Cvekl and Piatigorsky, 1996) .
The cornea is composed of a multilayered anterior epithelium, a thick extracellular collagenous stroma interspersed with keratocytes, and a single layer of posterior endothelial cells. Corneal transparency has been attributed mainly to the organized extracellular stroma (Maurice, 1957) . However, some proteins (e.g. aldehyde dehydrogenase and transketolase) are expressed at unexpectedly high levels in corneal cells Silverman et al., 1981; Abedinia et al., 1990; Cooper et al., 1991; Verhagen et al., 1991; Cuthbertson et al., 1992; Mitchell and Cenedella, 1995; Sax et al., 1996; Jester et al., 1999) . Such high expression of en zymes in the cornea is reminiscent of lens enzyme-crystallins. This has raised the possibility that tissue-speci®c gene expression in the lens and cornea has some common features that have not been appreciated previously (see Piatigorsky, 1998) . A possible link between tissue-speci®c gene expression in the lens and cornea is consistent with their ectodermal origin and expression of Pax-6 (Li et al., 1994; Koroma et al., 1997; see Cvekl and Piatigorsky, 1996) . The recent ®nding that the same upstream enhancer of Pax-6 is responsible for selective promoter activity in the lens and cornea of transgenic mice (Williams et al., 1998; Kammandel et al., 1999) supports the idea that speci®c gene expression is related in these two transparent tissues.
We have investigated a B-crystallin promoter activity in transgenic mice to test further the extent of similarity in speci®c gene expression in the lens and cornea. a B-crystallin is a stress-inducible small heat shock protein (Ingolia and Craig, 1982; Klemenz et al., 1991; de Jong et al., 1993) that is constitutively expressed highly in the lens and to a lesser extent in numerous other tissues. Outside of the lens, a Bcrystallin is expressed most highly in the heart and skeletal muscle (Bhat and Nagineni, 1989; Dubin et al., 1989; Iwaki et al., 1989 Iwaki et al., , 1990 Sax and Piatigorsky, 1994; Benjamin et al., 1997) . Of particular interest to the present work is its expression in the cornea (Robinson and Overbeek, 1996) .
Transgenic mouse experiments using reporter genes have shown that the developmental expression of the a B-crystallin gene is regulated at the transcriptional level (Dubin et al., 1991; Gopal-Srivastava and Piatigorsky, 1994; Haynes et al., 1996) . The a B-crystallin gene has an upstream enhancer (at positions 2426/2259) containing at least 5 cis-control elements that is essential for activity in non-lens tissues (Dubin et al., 1991; Gopal-Srivastava and Piatigorsky, 1993; Haynes et al., 1995; Gopal-Srivastava et al., 1995) . A proximal sequence (at positions 2164/144) is suf®cient for a B-crystallin promoter activity in the lens (GopalSrivastava and Piatigorsky, 1994) . The lens-speci®c sequence comprises 2 regions, LSR1 (2147/2118) and LSR2 (278 and 246), which can both be activated by Pax-6 (Gopal-Srivastava et al., 1996) and retinoic acid receptors (Gopal-Srivastava et al., 1998) in co-transfection experiments. Here we show that deleting the 5 H half of the enhancer eliminates a B-crystallin promoter activity in all tissues examined except the lens and corneal epithelium. Moreover, we show that the enhancer-free 2257/144 or 2164/144 a B-crystallin promoter fragment is suf®cient to drive the bacterial chloramphenicol acetyltransferase (CAT) reporter transgene speci®cally in both the lens and corneal epithelium of transgenic mice.
Results

Production of transgenic mice
Previously we have reported the expression patterns of the a B426-CAT and aB164-CAT transgenes in transgenic mice (Gopal-Srivastava and Piatigorsky, 1994) . The former has the bacterial CAT gene driven by the 2426/144 a Bcrystallin promoter fragment (which contains the 2426/ 2257 enhancer) and the latter has the CAT gene driven by the 2164/144 lens-speci®c promoter fragment (which lacks the enhancer). The 2426/2257 enhancer has ®ve known cis-elements (5 H a BE1, a BE4, a BE2, aBE3, MRF 3 H ) . The a B426-CAT transgenic mice showed CAT activity in multiple tissues, especially in heart, muscle and lens, while the a B164-CAT transgenic mice had CAT activity con®ned to the lens. In those experiments the cornea was not assayed for CAT activity in the transgenic mice. Here we have created several lines of transgenic mice from two additional constructs, aB339-CAT and a B257-CAT (Fig. 1A) . The enhancer has 87 bp of its 5 H sequence deleted in the a B339-CAT transgene, and lacks a BE1, aBE4 and the 5 H half of aBE2; the entire enhancer is deleted in the a B257-CAT transgene, which thus lacks all ®ve cis-control elements.
Polymerase chain reaction (PCR) analysis of tail DNA showed that four of the 26 F 0 mice had the a B339-CAT transgene and three of the seven F 0 mice had the a B257-CAT transgene in their genomes. All had multiple transgene copy numbers. Three lines in which the aB339-CAT or the aB257 transgenes were integrated in a single site were selected for further analysis (Table 1) .
Expression of the a B339-CAT and a B257-CAT transgenes in the transgenic mice
The CAT expression patterns in a typical experiment in a aB339-CAT and a a B257-CAT transgenic mouse are shown in Fig. 1B . Eight tissues were examined in each case (lung, heart, liver, spleen, kidney, thigh muscle, brain and lens). CAT activity was con®ned to the lens in these tissues in the aB339-CAT transgenic even though the transgene contained the 3 H half of the enhancer. A similar result was obtained in the aB257-CAT transgenic mouse that lacked the entire enhancer. Table 1 presents the data obtained for each mouse examined as well as for the nontransgenic control. In addition, Table 1 gives the average CAT values published previously (Gopal-Srivastava and Piatigorsky, 1994) for the a B164-CAT and a B426-CAT transgenic mice for comparison. The results were very similar for each mouse carrying the same transgene. There was no consistent relationship between the copy number and expression of the transgenes, indicating that the integration site of the transgene in¯uences the strength of its expression, as was found earlier (Gopal-Srivastava and Piatigorsky, 1994) . The average non-lens CAT activities of the aB339-CAT and a B257-CAT transgenic mice in the present study and the a B164-CAT transgenic mice in the previous study (Gopal-Srivastava and Piatigorsky, 1994) were similar to if not lower than the background levels observed in the non-transgenic mice.
Previously we showed that the average CAT activity in the lens of the a B426-CAT mice was seven times that of the aB164-CAT mice (Gopal-Srivastava and Piatigorsky, 1994) . Thus, even though the aB-crystallin enhancer is not critical for lens-speci®c promoter activity, it does increase the activity of this promoter in the lens. Comparison of the average CAT values derived from the aB339-CAT and a B257-CAT transgenic mice in the present study with those obtained previously for the a B426-CAT and a B164-CAT transgenic mice (see Table 1 ) con®rmed that the intact enhancer makes a signi®cant difference to the extent of expression of the transgene in the lens. The present results show that extending the lens-speci®c promoter fragment (aB164-CAT transgene) upstream up to the enhancer (aB257-CAT transgene) or even including the 3 H half of the enhancer (a B339-CAT transgene) does not increase the strength of promoter activity in the lens.
Corneal expression of the a B339-CAT and a B257-CAT transgenes in the transgenic mice
In earlier transgenic mouse experiments, as well as those presented above, we have con®ned our CAT assays in the eye to the lens. Since aB-crystallin is also found at lower concentrations in other eye tissues (Deretic et al., 1994; Flu Ègel et al., 1993; Robinson and Overbeek, 1996; Tamm et al., 1996) , we have now extended our observations within the eye. CAT activity was found in the cornea and retina of adult a B426-CAT transgenic mice, although at considerably lower amounts than that present in the lens (Fig. 2B ). In these experiments we used the diaphragm rather than the thigh for skeletal muscle expression; the diaphragm, as the thigh muscle (Table 1) , showed high CAT activity (more than cornea and retina) in the a B426-CAT mice. Unexpectedly, CAT activity was also present in the cornea of adult a B257-CAT transgenic mice despite the fact that this transgene lacks the a B-crystallin enhancer ( Fig. 2A) . Background values for CAT activity were obtained for the corneas of three separate non-transgenic mice of the same strain in order to assure that the activity measured in the a B257-CAT transgenic mice was indeed above background for this tissue. In all three cases, the background CAT activity was essentially zero (data not shown). We thus conclude that the enhancerless a B-crystallin promoter retains activity in the cornea, although at a lower level than in the lens. None of the other tissues including the retina had detectable CAT activity above background in the a B-257-CAT transgenic mice, consistent with the results obtained above.
We examined next a B-crystallin promoter activity in the cornea by histochemical staining for CAT (Fig. 3) . CAT activity was present in the lens but not in the cornea of the 16-day-old embryonic a B426-CAT transgenic mice (Fig. 3B) . The same results were obtained with 15-and 18-day-old embryos from another line of a B426-CAT transgenic mice (data not shown).
Although CAT activity was not observed in the corneas of the embryonic a B426-CAT transgenic mice (Fig. 3B) , staining for CAT activity was observed histochemically in the corneal epithelium of these mice at 4 weeks of age (Fig.  3E) , consistent with the experiment shown in Fig. 2B . The control section from the non-transgenic control mouse had negligible staining for CAT activity (Fig. 3C) . Similar results indicating CAT expression in the corneal epithelium were obtained in two additional lines of a B426-CAT transgenic mice (data not shown). We also observed histochemical staining for CAT activity in the corneal epithelium of the a B339-CAT transgenic mice at 5 weeks of age (data not shown). Corneal expression of the a B339-CAT transgene is consistent with corneal expression of the aB257-CAT transgene in transgenic mice: both constructs are active only in the lens and cornea.
Finally, we performed histochemical CAT assays on the cornea of the aB164-CAT transgenic mice to test more rigorously the ability of the enhancerless aB-crystallin promoter to function in the corneal epithelial cells. The results showed unequivocal CAT activity in the corneal epithelium of the 6-week-old a B164-CAT transgenic mice (Fig. 3D) that was above the background levels in Fig. 2 . Analysis of CAT activity in transgenic mice. Extracts from the speci®ed tissues were prepared from adult hemizygous (A) aB257-CAT and (B) aB426-CAT transgenic mice and assayed for CAT activity. the non-transgenic mice (Fig. 3C) . Similar results were obtained when the sections were not counterstained with hematoxylin to reduce the already low background even further (data not shown). The redder color of the stained corneal epithelium of the a B1644-CAT (Fig. 3D ) than of the aB426-CAT (Fig. 3E ) transgenic mouse is due to the lower promoter activity of the former than the latter, as expected. While we cannot exclude the possibility that a low level of CAT activity was present in the corneal stroma of the a B164-CAT transgenic mice, the CAT activity was concentrated in the corneal epithelium. No CAT activity above background was observed in sections that were subjected to comparable histochemical staining of the lung, brain, heart, skeletal muscle and kidney of the a B164-CAT transgenic mice (data not shown). By contrast, CAT activity was found by histochemistry in the heart (Gopal-Srivastava et al., 1995; data not shown) and skeletal muscle (data not shown) in the a B426-CAT transgenic mice; other tissues were not examined histologically in these mice. Taken together, we conclude that a functional enhancer is not required for a B-crystallin promoter activity in the lens and strati®ed corneal epithelium of transgenic mice.
Immunolocalization of a B-crystallin in the cornea and lens of wild-type mice
In view of our transgenic mouse results showing a B-crystallin promoter activity in the cornea, we performed immunohistochemistry tests on the normal cornea with a speci®c anti-bovine recombinant a B-crystallin antibody. Control preparations lacking the primary antibody showed no staining in the cornea or lens of 21-day-old mice (Fig. 4A) . In the experimental samples, strong staining was observed in the corneal epithelium as well as the in the epithelium and ®bers of the lens (Fig. 4B) . Similar results were obtained in 14-, 28-and 56-day-old eyes (data not shown). Weaker staining was observed in the lens epithelium than in the ®bers. No signi®-cant staining for a B-crystallin was observed in the stroma or endothelium of the cornea. Fig. 3 . Light photomicrographs of histochemical staining for CAT activity in eye tissues of mice harboring the aB164-CAT (panel D) and aB426-CAT (panels B and E) transgenes. The embryonic eyes (panels A and B) and the 4±6-week-old corneas (panels C±E) were stained for CAT activity as described in Section 4. (A) Control: no CAT activity staining is observed in the lens or the cornea of a 16-day-old wild-type embryo (E-16). (B) CAT activity staining in the embryonic (E-16) lens ®bers of an aB426-CAT transgenic mouse is indicated by an arrowhead. (C) 6-week-old wild-type cornea stained for CAT activity. (D) 6-week-old aB164-CAT transgenic mouse cornea stained for CAT activity. (E) 4-week-old a B426-CAT transgenic cornea stained for CAT activity. CAT activity staining was for 6 h in all cases. The frozen sections were counterstained with hematoxylin. le, lens epithelium; lf, lens ®bers; Epi, epithelium; Str, stroma, Endo, endothelium. Approximate magni®cations: A,B: £25. C±E: £75.
Discussion
The small heat shock protein, a B-crystallin, is a molecular chaperone (Horwitz, 1992 ) that is expressed constitutively in many ocular and non-ocular tissues (see Sax and Piatigorsky, 1994) . a B-crystallin accumulates in the lens where it is commonly accepted that it affects the optical and refractive properties of this transparent tissue. a B-crystallin (Flu Ègel et al., 1993) and its transcripts (Robinson and Overbeek, 1996) have also been found in the cornea. The role of a B-crystallin in the cornea and whether it affects its optical properties are not known. It is unlikely to act strictly as a crystallin since it is present at a much lower concentration in the cornea than in the lens. It is also noteworthy that no ocular abnormalities were noted in a B-crystallin null mice (Wawrousek and Brady, 1998) .
Previous experiments have shown that the a B-crystallin 2426/2259 enhancer is required to drive a B-crystallin promoter activity in non-lens tissues while the 2164/144 sequence is suf®cient for promoter activity in the lens of transgenic mice (Gopal-Srivastava and Piatigorsky, 1994) . The present experiments reveal two new ®ndings. First, the 5 H 87 bp sequence of the a B-crystallin enhancer is required for aB-crystallin promoter activity in all tissues tested except the lens and cornea of transgenic mice. Secondly, the a B-crystallin promoter either lacking the enhancer or containing a non-functional truncated enhancer is active in the corneal epithelium as well as the lens of transgenic mice. Thus, these data indicate that the speci®city of a B-crystallin promoter activity in the lens and cornea can be separated from that in other tissues, which requires the intact upstream enhancer.
Activity of the aB-crystallin enhancer
Previous DNase I footprinting, site-speci®c mutagenesis and transfection experiments have shown that the a B-crystallin enhancer is composed of at least 5 cis-elements (5 H aBE1, a BE4, a BE2, a BE3, MRF 3 H ). Moreover, transfection experiments indicated that a BE4 is used only in myocardial cells , that MRF is used selectively in skeletal muscle, heart and possibly lung cells Gopal-Srivastava et al., 1995; Haynes et al., 1995) , and that a BE3 is used in all the cell types that were examined except lung . The results obtained in the present study indicate that deletion of a BE1, a BE4 and the 5 H half of aBE2 inactivates the a B-crystallin promoter in all tissues tested except for the lens and cornea.
Relatively little is known about the transcription factors that are used for a B-crystallin enhancer activity. MyoD, myogenin or other family members bind to the E-box in MRF and are required for enhancer activity in skeletal muscle . We have proposed that MRF interacts with at least one additional element within the a B-crystallin enhancer for activity in skeletal muscle, since MRF contains only a single functionally critical E-box. In other genes it has been reported that one E-box is insuf®cient for activity (Weintraub et al., 1991) . Interaction of MRF with another a B-crystallin enhancer element is supported by the present transgenic mouse data showing that the truncated enhancer containing the intact MRF element is inactive in skeletal muscle. The MRF element is also essential for a B-crystallin enhancer function in transfected primary myocardiocytes, where it appears to bind USF rather than a MyoD family member (GopalSrivastava et al., 1995) . As for the other enhancer elements, the heart-speci®c a BE4 binds a serum response-like factor . a BE2 has an AP-2-like binding sequence although there is no direct evidence at the present time that AP-2 interacts with this aB-crystallin enhancer element. Virtually nothing is known about the transfactor(s) that bind a BE1. The present experiments focus attention on the functional importance of aBE1 and a BE2 and stress the need for identifying their cognate binding factors.
Expression of a B-crystallin in lens and cornea
Both the aB426-CAT and aB164-CAT transgenes were active in the corneal epithelium of our transgenic mice by 1 month after birth. Earlier time points after birth were not examined. The present immunohistochemistry data established that endogenous a B-crystallin is also expressed in the corneal epithelium of postnatal mice when the aBcrystallin promoter was found to be active in that tissue. We did not detect a B-crystallin promoter activity in the 15-to 18-day-old embryonic cornea of the transgenic mice. Moreover, in an earlier study a 4.5 kb a B-crystallin promoter-lacZ transgene was expressed in the developing lens but not in the cornea of the transgenic mouse embryos (Haynes et al., 1996) . a B-crystallin promoter activity was not examined in the eyes of the transgenic mice containing the 4.5 kb a B-crystallin promoter-lacZ transgene after birth.
The literature concerning a B-crystallin expression in the cornea contains discrepancies that need to be resolved. Flu Ègel et al. (1993) reported in immunocytochemistry and Western immunoblotting experiments that a B-crystallin is present in the endothelium, but not the epithelium, of adult primate and bovine corneas. An in situ hybridization study by Robinson and Overbeek (1996) reported weak staining for a B-crystallin mRNA in the corneal epithelium and endothelium of 13.5±15.5-day-old embryonic mice and in the epithelium of newborn mice. Robinson and Overbeek (1996) did not ®nd a B-crystallin mRNA in the corneal epithelium of 9-and 14-day-old mice; however, they did observe a B-crystallin mRNA in the corneal endothelium at these ages. Although we did not detect a B-crystallin promoter activity or a B-crystallin protein in the corneal endothelium, we did show both a B-crystallin promoter activity and a B-crystallin protein in the corneal epithelial cells in the 1-month-old mouse. Thus, our present data and that of Robinson and Overbeek (1996) establish that aBcrystallin is expressed in the mouse corneal epithelium after birth. However, a detailed study of a B-crystallin gene expression throughout corneal development and maturation in mice and other species is needed.
It is not known if the identical regulatory sequences or the same molecular mechanisms are used for a B-crystallin promoter activity in the corneal epithelium and lens of the mouse. Transgenic mouse and co-transfection experiments have demonstrated that the 2164/144 sequence contains at least two regulatory regions (LSR1 (2147/2118) and LSR2 (278/246)) that can be activated by Pax-6 and retinoic acid receptors (Gopal-Srivastava et al., 1996 , 1998 . Since Pax-6 and retinoic acid receptors are not con®ned to lens and cornea, other factors must be required for activity of the enhancerless, a B-crystallin promoter. The difference in a B-crystallin promoter activity in the lens (embryonic) and cornea (eye opening) observed in the present study suggests mechanistic differences between the two tissues. However, it remains possible that our methods were insuf®-ciently sensitive to detect the onset of a B-crystallin promoter activity in the embryonic corneal epithelium, an interpretation that would ®t with the results of Robinson and Overbeek (1996) .
It is of interest to note that an upstream enhancer in the mouse Pax-6 gene also functions selectively in the lens and cornea of transgenic mice (Williams et al., 1998; Kammandel et al., 1999) . We did not ®nd any striking similarity in the sequence of the Pax-6 enhancer and the a B-crystallin promoter (unpublished observations). Potential heat shock control elements (Sorger, 1991) are present at positions 295/221 of the a B-crystallin promoter and within the a B-crystallin enhancer, raising the possibility that inductive effects at eye opening contribute to the expression of a Bcrystallin in the cornea. This is consistent with the possibility that inductive effects associated with eye opening may contribute to the expression of aldehyde dehydrogenase 3 (Downes and Holmes, 1992; Boesch et al., 1996) and transketolase (Sax et al., 1996; Salamon et al., 1998) in the corneal epithelium (see Piatigorsky, 1998) . Whatever the precise mechanisms, our data show that the cis-control elements required for a B-crystallin promoter activity in the transparent lens and cornea can be separated from those required for promoter activity in other tissues. We believe that this ®nding will be useful to explore further the evolutionary strategies employed in the recruitment of this small heat shock protein for its functions in the lens and cornea (Piatigorsky, 1998) .
Materials and methods
Isolation of DNA
Plasmid DNA was prepared by the alkaline lysis method (Maniatis et al., 1989) followed by ultracentrifugation banding in CsCl-ethidium bromide. Mouse tail DNA was isolated as described elsewhere (Hogan et al., 1986) .
Production of transgenic mice
Approximately 2.7 kbp NdeI±PstI fragments containing the mouse a B-crystallin promoter-chloramphenicol acetyltransferase (CAT) fusion genes were isolated from plasmids p76-1 and p37-4 (Dubin et al., 1991) by polyacrylamide gel electrophoresis followed by electro-elution, phenol±chloro-form extraction and ethanol precipitation. Each fragment contained 60 bp of pBR322 sequence at its 5 H end, murine a B-crystallin promoter sequences, the bacterial CAT gene, and SV40-derived sequences including the small t-antigen splice sites and polyadenylation signal. The aB339-CAT fusion gene isolated from p76-1 contained the 2339/144 sequence, and the a B257-CAT fusion gene isolated from p37-4 contained the 2257/144 sequence of the a B-crystallin gene (Fig. 1) .
Linear DNA fragments were injected into one pronucleus of a single celled mouse embryo (FVB/N strain) obtained from superovulated FVB/N females. Injected embryos were transferred into CD1 females. The transgenic mice were made by the NEI transgenic mouse facility.
Analysis of transgenic mice
DNA was isolated (Hogan et al., 1986 ) from tails of founder F 0 mice and analyzed by Southern blot and PCR analyses for the presence of the transgene. We used 5
H oligodeoxynucleotide primers (oligo #10660 for a B339-CAT and oligo #10661 for aB257-CAT which were speci®c for the murine a B-crystallin promoter, and a 3 H oligodeoxynucleotide primer (oligo # 7576, 5
H -CGGTCTGGTTATAGG-TACATTGAGC-3 H ) which was speci®c for the CAT gene. F 0 mice containing the transgene were mated to nontransgenic FVB/N mice to obtain F1 offspring, and sibling matings were used to establish homozygous mouse lines. The transgene copy number for each mouse was estimated by hybridization intensity in a slot blot analysis of the genomic DNA relative to the standard samples representing 0±50 copies of the transgene, using the ECL-Oligo Labeling Detection System (RPN 2130/2131, Amersham) and the 1.6 kbp NdeI±BamHI fragment from pSVO-CAT as the labeled probe. Blots were exposed at room temperature for 1 min.
CAT assays
Hemizygous mice between 1 and 2 months of age were sacri®ced by CO 2 asphyxiation. The cornea, lung, heart, liver, kidney, spleen, brain (cerebrum) and skeletal muscle (thigh) samples were homogenized in the presence of 0.25 M Tris±HCl (pH 7.8) in a Duall glass homogenizer (Kontes, 0020). The lenses were homogenized in propylene Eppendorf microfuge tubes and centrifuged for 10 min at 48C. The supernatant fraction was heated at 658C for 15 min followed by centrifugation for 10 min. Protein concentrations were determined in the ®nal supernatant fraction with the BioRad protein assay kit according to the manufacturer's instructions using bovine serum albumin for the standard. Tissue extracts containing 0.5±20 mg of total protein were analyzed for CAT activity by the biphasic assay (Neumann et al., 1987) . The level of CAT activity was taken as an indirect measure of promoter strength.
Histochemical staining for CAT
Transgenic mice were sacri®ced by cervical dislocation, and the eyes removed and stored at 2808C in OCT. The eyes were sectioned in a cryostat to 5±10 mm, and the sections placed on gelatin-coated slides and ®xed in 5% paraformaldehyde for 10 min at 308C. In order to obtain embryonic eyes, mothers were killed by cervical dislocation, the embryos removed and their heads ®xed in 5% paraformaldehyde, rinsed in phosphate-buffered saline at pH 7.4 (PBS) and frozen in OCT at 2808C. Embryonic heads were sectioned in a cryostat to 10 mm and the sections placed on sialinated slides. All slides were stained for CAT activity by incubation in a mixture of sodium citrate, potassium ferricyanide, chloramphenicol, and acetyl coenzyme A for 6 h at room temperature (Donoghue et al., 1991) . Slides were washed brie¯y in water, counterstained with hematoxylin and mounted with aquamount for microscopic examination.
Immunohistochemical staining for a B-crystallin
Enucleated mouse eyes were ®xed in 4% paraformaldehyde, rinsed brie¯y in PBS, dehydrated through a graded ethanol series, embedded in paraf®n and 7-mm sections obtained. Selected sections were de-paraf®nized in xylene, re-hydrated through a graded ethanol series and rinsed in PBS. Immunolocalization of aB-crystallin was accomplished using an anti-bovine, recombinant aB-crystallin rabbit antibody (Horwitz et al., 1998 ; kindly provided by Dr. Joseph Horwitz, Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA) and the Vectastain Elite ABC detection system (Vector Laboratories, Burlingame, CA). This antibody was shown to be speci®c for aB-crystallin by Western immunoblotting analysis (Horwitz, unpublished data) . Brie¯y, sections were blocked for 20 min in normal serum diluted in PBS, followed by 2 h incubation with the a B-crystallin-speci®c primary antibody at a dilution of 1:2000 in PBS. Sections were then rinsed three times with PBS and incubated for 1 h in the biotinylated secondary antibody, followed by three changes of PBS and a 30-min incubation with the ABC reagent (avidin DH:biotinylated horseradish peroxidase H complex). The protein/antibody/peroxidase complex was visualized using the Vector VIP peroxidase substrate kit (Vector Laboratories). Reacted sections were rinsed brie¯y in water, dehydrated through a graded series of ethanol, cleared in xylene, and coverslips mounted using Permount (Fisher Scienti®c, Fair Lawn, NJ).
